Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rheumatoid Arthritis
|
2387 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.810 | 1.000 | 3 | 2012 | 2016 | |||||
Ankylosing spondylitis
|
609 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
142 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
132 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
141 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Autoimmune Diseases
|
428 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Autoimmune thyroiditis
|
76 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Celiac Disease
|
263 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Cholangitis, Sclerosing
|
276 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Crohn Disease
|
1147 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Graves Disease
|
352 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Hashimoto Disease
|
131 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Lymphocyte Count measurement
|
456 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Multiple Sclerosis
|
1022 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Psoriasis
|
705 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma
|
257 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Ulcerative Colitis
|
827 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Vitiligo
|
249 | 0.695 | 0.360 | 6 | 90267049 | intron variant | G/A | snv | 0.11 | 0.700 | 1.000 | 1 | 2016 | 2016 |